A sponge-like implant in mice has helped guide a treatment that slowed or stopped a degenerative condition similar to ...

A woman dubbed 'the world's most beautiful traffic warden' has shared a horrible health battle she has had to go through ...

Patients with mild atopic dermatitis who reported nighttime scratching experienced relief when they used an artificial ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

See a doctor who has experience with it. You’ll find dermatologists who have experience with cutaneous T-cell lymphoma at Find a Dermatologist. Click on "Filters". Select "Any condition" and choose ...

Type I interferon (IFN) score may effectively predict disease progression in limited cutaneous systemic sclerosis (lcSSc), with patients having a high IFN activity presenting worse clinical outcomes.

There is no drug tested for any autoimmune disease that has not also been tested for SSc, although none have proven to be effective. One of the main problems in reviewing therapies for SSc and ...

Patients showed no difference in skin fibrosis whether they were given low-dose oral glucocorticoids or not. One patient in each treatment group had scleroderma renal crisis. Low doses of ...

This injectable medication is administered under the skin (subcutaneously) once per week for three ... According to the National Multiple Sclerosis Society, vertigo and dizziness are common symptoms ...

Researchers Shed Light on How to Predict Which Skin Cancer Patients Are Most Likely to Respond to Immunotherapy Jan. 8, 2025 — An international team of UK and US scientists discovered that the ...

Results: The expression of DAX1 is upregulated in the skin of SSc patients in a TGFβ/JNK or TGFβ/ERK dependent manner. Inactivation of DAX1 by siRNA or by pharmaceutical inhibition ameliorated ...